Oncogene expression in T-cell lymphoproliferative disorders

Leuk Res. 1988;12(4):327-37. doi: 10.1016/0145-2126(88)90048-3.

Abstract

We have investigated the expression of oncogenes and other related genes in eleven patients with T-cell lymphoproliferative disorders and ten patients with other hematologic malignancies. The phenotypes of the T-cell disorders were determined using monoclonal antibodies specific for helper or suppressor subsets. RNA preparations were isolated from peripheral blood mononuclear cells and/or lymph node sections, 5'-end labeled with gamma-32P-ATP, and hybridized under stringent conditions to an excess of nitrocellulose-bound specific cloned DNA; autoradiographs were analysed by microdensitometry. Results revealed increased expression of K-ras, v-fps, transferrin receptor, alpha-tubulin and alpha-interferon in at least five of six helper T-cell lymphoproliferative disorders, while five of five suppressor T-cell disorders demonstrated levels of hybridization to these clones no higher than background. However, studies of T-suppressor disorders demonstrated enhanced levels of beta-interferon-specific RNA in five of five patients, an increase apparent in three of six T-helper chronic lymphoproliferative disorders. These results demonstrate different patterns of gene expression evident in T-helper and T-suppressor abnormalities.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Aged
  • Antibodies, Monoclonal
  • Female
  • Humans
  • Leukemia / genetics*
  • Lymphoma / genetics
  • Male
  • Middle Aged
  • Nucleic Acid Hybridization
  • Oncogenes*
  • T-Lymphocytes*
  • T-Lymphocytes, Helper-Inducer
  • T-Lymphocytes, Regulatory

Substances

  • Antibodies, Monoclonal